- Home
- AUPH vs HLIO Comparison
AUPH vs HLIO Comparison
Compare AUPH & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- HLIO
- Stock Information
- Founded
- AUPH 1993
- HLIO 1970
- Country
- AUPH Canada
- HLIO United States
- Employees
- AUPH N/A
- HLIO N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- HLIO Metal Fabrications
- Sector
- AUPH Health Care
- HLIO Industrials
- Exchange
- AUPH Nasdaq
- HLIO Nasdaq
- Market Cap
- AUPH 1.1B
- HLIO 1.0B
- IPO Year
- AUPH 1999
- HLIO N/A
- Fundamental
- Price
- AUPH $8.19
- HLIO $32.33
- Analyst Decision
- AUPH Strong Buy
- HLIO Buy
- Analyst Count
- AUPH 2
- HLIO 3
- Target Price
- AUPH $11.50
- HLIO $44.00
- AVG Volume (30 Days)
- AUPH 1.4M
- HLIO 409.6K
- Earning Date
- AUPH 07-31-2025
- HLIO 08-04-2025
- Dividend Yield
- AUPH N/A
- HLIO 1.11%
- EPS Growth
- AUPH N/A
- HLIO 11.74
- EPS
- AUPH 0.27
- HLIO 1.11
- Revenue
- AUPH $247,295,000.00
- HLIO $789,400,000.00
- Revenue This Year
- AUPH $12.15
- HLIO N/A
- Revenue Next Year
- AUPH $18.31
- HLIO $4.69
- P/E Ratio
- AUPH $30.78
- HLIO $29.14
- Revenue Growth
- AUPH 29.20
- HLIO N/A
- 52 Week Low
- AUPH $5.15
- HLIO $24.76
- 52 Week High
- AUPH $10.67
- HLIO $57.29
- Technical
- Relative Strength Index (RSI)
- AUPH 54.75
- HLIO 56.78
- Support Level
- AUPH $7.91
- HLIO $28.79
- Resistance Level
- AUPH $8.07
- HLIO $32.66
- Average True Range (ATR)
- AUPH 0.24
- HLIO 1.17
- MACD
- AUPH -0.00
- HLIO 0.09
- Stochastic Oscillator
- AUPH 51.85
- HLIO 85.59
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.